Testing treatments to improve symptoms of Myositis - Wesley Research Institute
Wesley Research Institute

Myositis is a disorder in which the immune system attacks the muscles. It is hoped that this new treatment may help improve the symptoms of this disease.


Research Objectives





Patient Group

Idiopathic Inflammatory Myopathy/Myositis Status: Current

Study location

Wesley Research Institute



Study type

Industry Sponsored
Sponsors: Argenx BV (global) and ICON Clinical Research Pty Ltd (Local)

Lead investigators

  • Dr Daman Langguth

Clinical Trial Coordinator

  • Venita Bali

Technical title

A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathies

About this research project

The research project is testing a new treatment for Active Idiopathic Inflammatory Myopathy. This is a disorder in which the immune system attacks the muscles. This leads to muscle weakness and may affect other organs of the body.

The potential new treatment being tested is called efgartigimod (also called ARGX113). It is hoped that efgartigimod may help improve the symptoms of myositis.


Latest News

Mitsubishi Development announces largest Australian partnership

On Thursday 6 July Wesley Research Institute and Mitsubishi Development signed a new partnership, the largest for Mitsubishi Development in Australia, which will provide significant funding for Navicare over the next two years.
Maureen Stevenson accepting her 2023 Queensland Community Philanthropist of the Year Award

Maureen Stevenson Award

Maureen Stevenson received the 2023 Community Philanthropist of the Year Award at the Queensland Philanthropy Awards (QCF) held at Brisbane Town Hall.
Andrew Barron, Mandy Maysey and Dr Phil Mosley

Australian scientists prove medicinal cannabis can be a lifechanging treatment for people with Tourette Syndrome

Imagine the pain and embarrassment of violent movements and uncontrollable outbursts at school or work…that’s what life was like for Chris Wright (35) before he started a ground-breaking clinical trial of medicinal cannabis.
1 2 3 6
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram